Gene patents: Are they socially acceptable monopolies, essential for drug discovery? - Reply

Drug Discovery Today

Volumn 7, Issue 1, 2002, Pages 23-24

  Heinemann, Jack A ^a,b  

^a UNIVERSITY OF CANTERBURY   (New Zealand)

^b University of Tromsö   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATASE; DNA; NUCLEOTIDE;

DNA SEQUENCE; GENE; GENE ACTIVITY; GENE EXPRESSION; GENE STRUCTURE; METHYLATION; PATENT; PHENOTYPE; PROTEIN ANALYSIS; PROTEIN DOMAIN; SHORT SURVEY; DRUG INDUSTRY; ETHICS; GENETICS; LETTER;

DNA; DRUG INDUSTRY; INTELLECTUAL PROPERTY; PATENTS;

EID: 0036007205     PISSN: 13596446     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1359-6446(01)02106-7     Document Type: Note

References (14)

1. Gene patents: Are they socially acceptable monopolies, essential for drug discovery?
2. Propagating epigenetic states through meiosis: Where Mendel's gene is more than a DNA moiety
3. Enzyme induction as an all-or-none phenomenon
4. Gene patents: Socially acceptable monopolies or an unnecessary hindrance to research?
5. Evolutionary implications of the frequent horizontal transfer of mismatch repair genes
6. Lateral transfer at the gene and subgenic levels in the evolution of eukaryotic enolase
7. Evolution of an autotransporter: Domain shuffling and lateral transfer from pathogenic Haemophilus to Neisseria
8. Were protein internal repeats formed by 'bricolage'?
9. New hypotheses on the material nature of horizontally transferred genes
10. Horizontal transfer of proteins between species: Part of the big picture of just a genetic vignette?
11. Human morbid genetics revisited: Relevance of epigenetics
12. Cancer epigenetics comes of age